soul trial oral semaglutide cardiovascular outcomes nejm 2025 results Trial Scorecard: SOUL New in the May 29,

Fasting serum insulin levels also decreased by up to 70.9% after 48 weeks, which may improve insulin resistance but may require additional monitoring in certain patients

They can be injected into the muscle, usually in the arm or buttock

Hippocampal GLP-1 Receptors Influence Food Intake, Meal Size, and Effort-Based Responding for Food through Volume Transmission

Insulin sensitivity in patients with primary aldosteronism: a follow-up study

According to experts, Semaglutide may cause bloating, belching, stomach upset, and blurred vision

Meanwhile, GLP-1s such as Ozempic (semaglutide) and Trulicity (dulaglutide) are very effective at managing post-meal blood sugars, have a low risk of hypoglycemia, and help with weight loss